SCHEMBL27317552

SCHEMBL27317552

C[C@@H](C#N)c1cncc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 5/20 0.39
ADRA2B P18089 5/20 0.39
ADRA2C P18825 5/20 0.39
ADRA1A P35348 4/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1B P35368 2/20 0.39
CYP11B2 P19099 6/20 0.38
CYP11B1 P15538 5/20 0.38
HTT P42858 1/20 0.38
PIP4K2A P48426 1/20 0.37
PRKCZ Q05513 1/20 0.37
SLC22A12 Q96S37 3/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2B6 P20813 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27317342 1.00 ADRA2A (0.39) ADRA2AADRA2BADRA2CADRA1AADRA1D
SCHEMBL27317554 1.00 ADRA2A (0.39) ADRA2AADRA2BADRA2CADRA1AADRA1D
SCHEMBL27317248 0.83 HTT (0.41) CYP11B2CYP11B1HTTPIP4K2ACYP1A2
SCHEMBL27317245 0.81 HTT (0.40) CYP11B2CYP11B1HTTPIP4K2ACYP1A2
SCHEMBL29875062 0.80 ADRA2A (0.44) ADRA2AADRA2BADRA2CADRA1AADRA1D
SCHEMBL2607435 0.80 ADRA2A (0.44) ADRA2AADRA2BADRA2CADRA1AADRA1D
SCHEMBL27234578 0.79 PRKCZ (0.40) ADRA2AADRA2BADRA2CADRA1AADRA1D
SCHEMBL10399086 0.78 ALDH1A1 (0.50) ADRA2AADRA2BADRA2CADRA1AADRA1D
SCHEMBL27317358 0.78 CYP11B1 (0.37) CYP11B2CYP11B1SLC22A12
SCHEMBL27317664 0.78 CYP11B2 (0.37) CYP11B2CYP11B1SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024102986-A2 SARS-COV-2 MPRO INHIBITORS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2024-05-16 WO disclosed